3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
196
Triple Negative Breast Neoplasms
26
Neoplasm Metastasis
18
Breast Neoplasms, Male
13
Ovarian Neoplasms
9
Inflammatory Breast Neoplasms
9
Pancreatic Neoplasms
8
Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Stomach Neoplasms
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Recurrence
2
Multiple Myeloma
2
Lymphedema
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Brain Neoplasms
2
Uterine Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Interventions
trastuzumab deruxtecan
2
neratinib
1
Radiosurgery
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Cancer With Brain Metastasis
×
Bevacizumab
×
Breast
×
Clear all
NCT07150208
2025-09-02
THUMB
Fudan University
Phase 2
Not yet recruiting
140 enrolled